Sia Partners
Additional information
| Capability | |
|---|---|
| Industry | |
| Language |
Description
Pharmaceutical companies are increasingly having to forge partnerships, mainly due to the rising cost of research and development, the increase in the bargaining power of buyers, more and more restrictive regulations, or the evolution towards an integrated care offer. While strategic alliances may seem time-consuming to implement and complex to manage, they nevertheless offer an interesting “benefit-risk ratio” that explains their growing use. In this article, we will recall the principles of a strategic alliance. We will then present their current uses in the pharmaceutical industry and identify the associated key success factors.
Only logged in customers who have purchased this product may leave a review.
You may also like
-
Oliver WymanAutomotive 2030
Building The Automotive Industry of 2030
$0.00 Oliver Wyman
-
DeloitteSUPPLY chains traditionally are linear in nature, with a discrete progression of design, plan, source, make, and deliver. Today, however, many supply chains are transforming from a staid sequence to a dynamic, interconnected system that can more readily incorporate ecosystem partners and evolve to a more optimal state over time.
The rise of the digital supply network
$0.00 Deloitte
-
Alix PartnerNew technologies are fundamentally disrupting the business model for consumer products companies around the world. Relationships between manufacturers and retailers – and the consumers they share – are changing, and new business models are emerging. This is a challenge, certainly, but also a tremendous opportunity.
Achieving Profitable Growth in Consumer Products
$0.00 Alix Partner
Trouble with Conavigo
Trouble with Conavigo?
Contact our support team if you have trouble with the search results, your account, or your message box. We are here to help.
Ads Customers
Ads Consultants
Ads Students
Reviews
There are no reviews yet.